Specialties
Lee G Wilke, MD, FACS
Professor
- Senior Medical Director, Clinical Cancer Services; UW Health/UW Carbone Cancer Center
- Professor, Division of Surgical Oncology
- Hendricks Chair in Breast Cancer Surgery Research
wilke@surgery.wisc.edu
(608) 263-7064
- Administrative Assistant: (608) 262-2025
600 Highland Avenue
Box 7375 Clinical Science Center
Madison, WI 53792
Education
- MD, Duke University, Durham, NC
- Residency in Surgery, University of Michigan, Ann Arbor, Michigan
- ACS Resident Research Fellow in Immunotherapy, University of Michigan, Ann Arbor, MI
Clinical Specialties
Dr. Wilke is certified by the American Board of Surgery and specializes in benign and malignant diseases of the breast; sentinel lymph-node mapping; neoadjuvant therapy for breast cancer; and oncoplastic breast surgery.
Dr. Wilke provides a wide range of services including Axillary Lymph Node Dissection, Core Needle Biopsy, Lumpectomy or Partial Mastectomy, Modified Radical Mastectomy, Needle-localized Biopsy, Needle-localized Excision, Sentinel Lymph Node Biopsy, Simple Mastectomy, Skin-sparing and/or Nipple-sparing Mastectomy.
Research Interests
Dr. Wilke’s principal research interest is in clinical trials seeking novel methods of treating patients with breast cancer. Dr. Wilke is lead Principal investigator for the UW Carbone Cancer Center NCTN Lead Academic Program UG1 Grant and a Board member for the NCCN and NAPBC. She is a collaborator on multiple grants and trials evaluating novel medical and surgical treatments for breast cancer.
Recent Publications
Correction: An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients: From the Society of Surgical Oncology and the American Society of Breast Surgeons.
Weiss A, Agnese DM, Al-Hilli Z, Cabioglu N, Farr D, Kantor O, Obeng-Gyasi S, Wilke L
Ann Surg Oncol 2025 Aug; 32(8): 5592
[PubMed ID: 40399602]An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients: From the Society of Surgical Oncology and the American Society of Breast Surgeons.
Weiss A, Agnese DM, Al-Hilli Z, Cabioglu N, Farr D, Kantor O, Obeng-Gyasi S, Wilke L
Ann Surg Oncol 2025 Aug; 32(8): 5453-5466
[PubMed ID: 40355803]Orchestrating Cancer Care-Will the Surgeon Always Participate?
Wilke LG, Lautner MA
JAMA Surg 2025 May 07;
[PubMed ID: 40332930]ASO Visual Abstract: Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data.
Fefferman ML, Thompson DM, Wilke LG, Hwang S, Bleicher R, Freedman LM, Meisel JL, Kuchta K, Yao K
Ann Surg Oncol 2025 Mar; 32(3): 2112-2113
[PubMed ID: 39786682]Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data.
Fefferman ML, Thompson DM, Wilke LG, Hwang S, Bleicher R, Freedman LM, Meisel JL, Kuchta K, Yao K
Ann Surg Oncol 2025 Mar; 32(3): 2045-2055
[PubMed ID: 39658720]